Professor David Ashley Appointed to New Role at WEHI
Renowned immuno-oncologist Professor David Ashley has been appointed to a new position at the Walter and Eliza Hall Institute of Medical Research (WEHI).
The appointment aims to enhance WEHI's collaboration within the Victorian Comprehensive Cancer Centre (VCCC) Alliance, with a specific focus on brain cancer research and translation.
Expertise in Brain Cancer
Professor Ashley has shaped immunotherapy approaches for both pediatric and adult brain tumors. He has also led the translation of key discoveries into early-phase clinical trials.
"Professor Ashley's neuro-oncology expertise and global perspective will help advance collective efforts to improve outcomes for people with brain cancer."
— Professor Ken Smith, WEHI Director
Strengthening Collaboration
The new role is intended to strengthen partnerships across the VCCC Alliance and accelerate progress in brain cancer research.
Industry Support
Sam McGuane, CEO of The Brain Cancer Centre, welcomed the appointment.
"Professor Ashley's insights will enrich our collaborative model and expand our ability to unite scientists, clinicians, and partners in tackling brain cancer."